Morrisville, N.C.-based biotechnology company Novan Inc. appointed Eugene Sun to the board, effective Feb. 16.
Sun was CEO of Melinta Therapeutics from 2015 to 2017. He also served on the now-defunct U.S. Food and Drug Administration's Antiviral Drugs Advisory Committee, a panel of infectious disease experts, from 2001 to 2007.
